Login
$ATRC
$55.31 -$1.53 (2.69%) Live

$ATRC 8-K/A SEC Filings

Filed On Filing
06 May 2026 8-K/A: Results of Operations and Financial Condition

MASON, Ohio, May 6, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

29 Oct 2025 8-K/A: Results of Operations and Financial Condition

MASON, Ohio, October 29, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno...

27 Feb 2024 8-K/A: Departure/Election of Directors or Officers; Compensation

On January 4, 2024 AtriCure, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) reporting that the Company’s Board of Directors (the “Board”) elected Shlomi Nachman to serve as a director until the Company’...

24 Oct 2019 8-K/A: Financial Statements and Exhibits

We have audited the accompanying consolidated financial statements of SentreHEART, Inc. (the Company) and its subsidiary, which comprise the consolidated balance sheets as of December 31, 2018 and 2017, the related consolidated statement...

02 Mar 2017 8-K/A: Results of Operations and Financial Condition

MASON, Ohio, February 28, 2017 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced fourth quarter and full year 2016 financial resu...

10 Nov 2015 8-K/A: Financial Statements and Exhibits

On October 14, 2015, AtriCure, Inc. (“AtriCure” or the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) to report the Company’s acquisition of nContact (defined below) pursuant to the Merger Agreement, dated as of Oc...

13 Mar 2014 8-K/A: Financial Statements and Exhibits

On January 2, 2014, AtriCure, Inc. (“AtriCure” or the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) to report the Company’s acquisition of Estech (defined below) pursuant to the Merger Agreement, dated as of Decem...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support